K081729 is an FDA 510(k) clearance for the MODIFICATION TO GFX NERVE ABLATION SYSTEM. Classified as Generator, Lesion, Radiofrequency (product code GXD), Class II - Special Controls.
Submitted by Bioform Medical, Inc. (Franksville, US). The FDA issued a Cleared decision on August 7, 2008 after a review of 50 days - a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4400 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.